| Business Summary | | Spectrum
Laboratories,
Inc.
is
engaged
in
the
development
and
commercialization
of
proprietary
tubular
membranes
and
membrane
devices
for
existing
and
emerging
life
sciences
applications.
These
products
are
used
by
life
science
research
laboratories
for
emerging
applications
for
molecular/biological
separations,
fluid
purification
and
cell
expansion/bioreactors.
The
Company's
proprietary
products
are
used
for
research
by
original
equipment
manufacturers
(OEM)
and
for
process
separations
of
pharmaceutical
compounds.
Most
laboratory
products
are
sold
through
laboratory
distributors.
OEM
and
private
label
products
are
sold
primarily
to
manufacturers.
They
include
re-sale
versions
of
the
Company's
laboratory
products
as
well
as
specially
designed
membrane
products. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | Spectrum
Laboratories
is
engaged
in
the
development
and
commercialization
of
proprietary
tubular
membranes
and
membrane
devices
for
existing
and
emerging
life
sciences
applications.
For
the
six
months
ended
6/30/01,
revenues
decreased
5%
to
$6.5
million.
Net
income
decreased
55%
to
$247
thousand.
Revenues
reflect
a
decline
in
customer
demand.
Net
income
also
reflects
lower
margin
sales
and
increased
S/G/A
and
research
and
development
expenditures. | More
from
Market Guide: Significant
Developments |
| Officers | | | FY2000 Pay | |
| Roy Eddleman, 61 Chairman
and CEO | $591K | F. Jesus Martinez, 61 Pres
and COO | 145K | Larry Womack, 61 CFO,
VP-Fin. | -- | Malcolm Morrison, Ph.D., 58 VP
of Operations | -- | Robert Sudol, 53 VP
of Sales and Marketing | -- | Dollar amounts are as of 30-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|